NAMED PATIENT PROCESS (NPP)
OrphanDC provides patients and physicians, in Brazil & Argentina, with the opportunity to access medicines, commercially approved abroad, in their own country. Named Patient Process, aka Named Patient Sale is viable and a soft-landing opportunity in both territories.
Picture5.png
PARTICULARITIES IN BRAZIL & ARGENTINA
Picture11.png

9 to 12 months market access prediction

75% predicted market acceptance

2 to 3 months market access prediction

90% predicted market acceptance